We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$7.46B
AUM Growth
+$995M
Cap. Flow
-$777M
Cap. Flow %
-10.41%
Top 10 Hldgs %
43.11%
Holding
851
New
66
Increased
156
Reduced
545
Closed
77

Top Buys

Rank Stock Value
1
OKE icon
Oneok
OKE
+$19.7M
2
NWL icon
Newell Brands
NWL
+$17.6M
3
NEM icon
Newmont
NEM
+$6.91M
4
COTY icon
Coty
COTY
+$5.93M
5
VIR icon
Vir Biotechnology
VIR
+$5.4M

Sector Composition

Rank Sector Weight
1 Energy 52.96%
2 Financials 9.94%
3 Healthcare 5.17%
4 Technology 4.58%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORA icon
126
Ormat Technologies
ORA
$6.11B
$9.2M 0.12%
144,938
+19,073
+15% +$1.25M
AYI icon
127
Acuity Brands
AYI
$9.88B
$9.16M 0.12%
95,654
+8,995
+10% +$791K
AAPL icon
128
Apple
AAPL
$4.89T
$8.62M 0.12%
94,548
-57,260
-38% -$4.44M
HASI icon
129
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
$8.44M 0.11%
296,568
+64,715
+28% +$1.77M
EMLC icon
130
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
$7.91M 0.11%
257,316
-4,790
-2% -$142K
CWEN icon
131
Clearway Energy Class C
CWEN
$5B
$7.63M 0.1%
331,042
+49,518
+18% +$1.05M
UTHR icon
132
United Therapeutics
UTHR
$26.3B
$7.26M 0.1%
60,036
-17,775
-23% -$2M
AU icon
133
AngloGold Ashanti
AU
$40.3B
$7.2M 0.1%
244,258
+168,276
+221% +$4.16M
VDC icon
134
Vanguard Consumer Staples ETF
VDC
$7.86B
$7.13M 0.1%
47,687
+410
+0.9% +$60.8K
XLRN
135
DELISTED
Acceleron Pharma
XLRN
$7M 0.09%
73,421
-13,244
-15% -$1.28M
RUN icon
136
Sunrun
RUN
$2.37B
$6.88M 0.09%
348,685
+52,121
+18% +$798K
HL icon
137
Hecla Mining
HL
$10.2B
$6.81M 0.09%
2,083,216
-264,119
-11% -$729K
MRTX
138
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.8M 0.09%
59,530
-17,470
-23% -$1.69M
TERP
139
DELISTED
TerraForm Power, Inc
TERP
$6.73M 0.09%
365,179
+51,309
+16% +$908K
VIR icon
140
Vir Biotechnology
VIR
$1.47B
$6.59M 0.09%
+160,827
New +$5.4M
V icon
141
Visa
V
$677B
$6.06M 0.08%
31,389
+2,490
+9% +$455K
ARWR icon
142
Arrowhead Research
ARWR
$12.1B
$6M 0.08%
+138,841
New +$4.9M
CDE icon
143
Coeur Mining
CDE
$15.6B
$6M 0.08%
1,180,154
+949,232
+411% +$4.32M
KKR icon
144
KKR & Co
KKR
$89.2B
$5.99M 0.08%
194,119
-50,136
-21% -$1.35M
BX icon
145
Blackstone
BX
$104B
$5.8M 0.08%
102,382
-21,843
-18% -$1.15M
BPMC
146
DELISTED
Blueprint Medicines
BPMC
$5.77M 0.08%
+73,921
New +$5M
MOR
147
DELISTED
MorphoSys AG American Depositary Shares
MOR
$5.68M 0.08%
179,460
-51,270
-22% -$1.49M
EBS icon
148
Emergent Biosolutions
EBS
$375M
$5.66M 0.08%
+71,518
New +$5.33M
VBR icon
149
Vanguard Small-Cap Value ETF
VBR
$37.1B
$5.5M 0.07%
51,421
GBT
150
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.25M 0.07%
83,128
-26,109
-24% -$1.79M

Similar funds

ALPS Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, ALPS Advisors held 851 positions worth $7.46B, up 15% from $6.46B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

ALPS Advisors withdrew a net $777M in Q2 2020, closing 77 positions and reducing 545 holdings. Its most notable exit was EQM Midstream Partners, LP, an estimated $127M position sold in full.

By sector, the portfolio is most concentrated in Energy at 53% of assets, up from 51% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Newell Brands worth $20.3M.

  • ALPS Advisors's largest Q2 2020 buy was Newell Brands: 1,279,812 shares worth $20.3M.
  • ALPS Advisors added most to Oneok in Q2 2020, an estimated $19.7M increase.
  • ALPS Advisors's biggest Q2 2020 reduction was MPLX, cutting an estimated $139M.
  • ALPS Advisors fully exited EQM Midstream Partners, LP in Q2 2020, selling an estimated $127M.
  • ALPS Advisors's ten largest holdings make up 43% of its $7.46B portfolio in Q2 2020.
  • ALPS Advisors opened 66 new positions and closed 77 in Q2 2020.
  • ALPS Advisors's portfolio value rose 15% quarter-over-quarter to $7.46B.

Based on ALPS Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.